Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Impact of Obesity on GVHD Following Post-Transplantation Cyclophosphamide in Patients Undergoing Allogeneic Hematopoietic Cell Transplant | Synapse
March 3, 2026
Impact of Obesity on GVHD Following Post-Transplantation Cyclophosphamide in Patients Undergoing Allogeneic Hematopoietic Cell Transplant
NA
Naveed J. Ali
AH
Alycia Hatashima
University of Washington
XF
Xinyi Fan
Ver todo
Puntos clave
Obesity significantly raises the risk of graft-versus-host disease (GVHD) after transplantation.
Patients with higher body mass indexes may experience more severe immune responses post-transplant.
Assessment through a detailed investigation involving multiple centers and patient records unveiled key patterns in outcomes.
This highlights the importance of considering obesity when predicting GVHD in transplant patients.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Ali et al. (Sun,) studied this question.
synapsesocial.com/papers/69a760dfc6e9836116a2e078
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.668